QR kód

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry

Abstract Background Stroke prevention with oral anticoagulant (OAC) therapy, including non-vitamin K antagonist oral anticoagulants (NOACs), is recommended in patients with atrial fibrillation (AF). This analysis describes the antithrombotic prescription patterns for Chinese patients enrolled post-d...

Celý popis

Uloženo v:
Hlavní autoři: Xiaoxia Liu, Guoze Feng, Sabrina Vogel Marler, Menno V Huisman, Gregory Y. H. Lip, Changsheng Ma
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2023-08-01
Edice:Thrombosis Journal
Témata:
Atrial fibrillation
Oral anticoagulation
Stroke
Prevention
China
On-line přístup:https://doi.org/10.1186/s12959-023-00527-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky